STAAR Surgical Company (STAA): Price and Financial Metrics

STAAR Surgical Company (STAA): $59.79

0.47 (+0.79%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

STAA Price/Volume Stats

Current price $59.79 52-week high $112.27
Prev. close $59.32 52-week low $46.35
Day low $58.54 Volume 440,700
Day high $60.79 Avg. volume 671,357
50-day MA $64.93 Dividend yield N/A
200-day MA $69.14 Market Cap 2.89B

STAA Stock Price Chart Interactive Chart >

STAA POWR Grades

  • Quality is the dimension where STAA ranks best; there it ranks ahead of 87.63% of US stocks.
  • STAA's strongest trending metric is Growth; it's been moving down over the last 179 days.
  • STAA's current lowest rank is in the Stability metric (where it is better than 14.46% of US stocks).

STAA Stock Summary

  • With a price/earnings ratio of 91.5, STAAR SURGICAL CO P/E ratio is greater than that of about 94.19% of stocks in our set with positive earnings.
  • The price/operating cash flow metric for STAAR SURGICAL CO is higher than 95.72% of stocks in our set with a positive cash flow.
  • With a price/sales ratio of 9.89, STAAR SURGICAL CO has a higher such ratio than 89.36% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to STAAR SURGICAL CO are SSTK, SLP, OSIS, LMAT, and VZIO.
  • STAA's SEC filings can be seen here. And to visit STAAR SURGICAL CO's official web site, go to www.staar.com.

STAA Valuation Summary

  • In comparison to the median Healthcare stock, STAA's price/sales ratio is 340.91% higher, now standing at 9.7.
  • STAA's price/sales ratio has moved up 6.2 over the prior 243 months.

Below are key valuation metrics over time for STAA.

Stock Date P/S P/B P/E EV/EBIT
STAA 2023-05-23 9.7 8.4 89.4 81.0
STAA 2023-05-22 10.6 9.2 97.7 88.7
STAA 2023-05-19 10.4 9.0 96.0 87.1
STAA 2023-05-18 10.5 9.1 96.9 87.9
STAA 2023-05-17 10.2 8.9 94.5 85.7
STAA 2023-05-16 10.1 8.8 93.8 85.0

STAA Growth Metrics

    Its 3 year price growth rate is now at 100.06%.
  • The 4 year revenue growth rate now stands at 82.95%.
  • The 5 year price growth rate now stands at 268.93%.
STAA's revenue has moved up $73,150,000 over the prior 15 months.

The table below shows STAA's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 279.348 41.243 37.824
2022-06-30 261.654 39.45 33.582
2022-03-31 242.92 32.586 29.111
2021-12-31 230.472 43.962 24.501
2021-09-30 217.469 55.014 22.906
2021-06-30 206.198 42.287 20.778

STAA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • STAA has a Quality Grade of B, ranking ahead of 92.6% of graded US stocks.
  • STAA's asset turnover comes in at 0.762 -- ranking 41st of 186 Medical Equipment stocks.
  • NVNO, ADMT, and BLFS are the stocks whose asset turnover ratios are most correlated with STAA.

The table below shows STAA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-10-01 0.762 0.772 0.342
2021-07-02 0.784 0.764 0.341
2021-04-02 0.734 0.741 0.208
2021-01-01 0.713 0.724 0.110
2020-10-02 0.722 0.722 0.087
2020-07-03 0.720 0.722 0.056

STAA Price Target

For more insight on analysts targets of STAA, see our STAA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $147.00 Average Broker Recommendation 1.5 (Moderate Buy)

STAAR Surgical Company (STAA) Company Bio


STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye, and delivery systems to deliver lenses into the eye. The company was founded in 1982 and is based in Monrovia, California.


STAA Latest News Stream


Event/Time News Detail
Loading, please wait...

STAA Latest Social Stream


Loading social stream, please wait...

View Full STAA Social Stream

Latest STAA News From Around the Web

Below are the latest news stories about STAAR SURGICAL CO that investors may wish to consider to help them evaluate STAA as an investment opportunity.

2 Stocks With Unstoppable Growth Potential for the Next Decade

When a business is making headway in a massive and uncontested global market, shareholders reap the benefits. The result could well be a run of wild growth over the next few years. Align Technology's (NASDAQ: ALGN) business model is simple: It sells its Invisalign tooth straighteners to dentists and orthodontists, who use its scanning and 3D modeling devices to adapt the straighteners to fit their patients -- thus eliminating the need to get traditional braces.

Yahoo | May 17, 2023

STAAR Surgical (NASDAQ:STAA) Shareholders Will Want The ROCE Trajectory To Continue

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Yahoo | May 9, 2023

EVO ICL Sponsors Jonas Brothers’ The Tour

LAKE FOREST, Calif., May 04, 2023--EVO ICL, the vision correction procedure that works in harmony with your natural eye, provides sharp, clear vision day or night and does not cause contact lens induced dry eye or dry eye syndrome, announced today sponsorship of the Jonas Brothers’ The Tour in North America, which begins August 12. Collaboration with the group will also include a new EVO advertising campaign slated for launch in the fall of 2023. The campaign will help drive education and awaren

Yahoo | May 4, 2023

Staar Surgical (STAA) Beats Q1 Earnings and Revenue Estimates

Staar Surgical (STAA) delivered earnings and revenue surprises of 63.64% and 10.82%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | May 3, 2023

STAAR Surgical Reports First Quarter 2023 Results

LAKE FOREST, Calif., May 03, 2023--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today reported financial results for the first quarter ended March 31, 2023.

Yahoo | May 3, 2023

Read More 'STAA' Stories Here

STAA Price Returns

1-mo -15.16%
3-mo 7.94%
6-mo 4.69%
1-year -10.81%
3-year 54.10%
5-year 104.41%
YTD 23.18%
2022 -46.83%
2021 15.25%
2020 125.25%
2019 10.22%
2018 105.87%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8818 seconds.